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Podium Presentations: Tuesday, July 16, 2019P892preventable dementia in South Africa is hampered by the lack of
epidemiological data. Our planned research will improve preva-
lence and risk estimates for known and emerging dementia risk
factors.O3-05-06 GLOBAL COUNCIL ON BRAIN HEALTHLIFESTYLE RECOMMENDATIONS FOR
ADULTS 50+Sarah Lenz Lock, Lindsay Rachel Chura, Nicholas Barraccca,
AARP, Washington, DC, USA. Contact e-mail: SLock@aarp.orgBackground: Lifestyle modifications are at the heart of efforts to
promote healthy aging and risk reduction for cognitive decline
and dementia. The Global Council on Brain Health (GCBH) is an
independent collaborative of scientists, clinicians, scholars and pol-
icy experts convened by AARP to provide evidence-based advice
on what people and professionals can do to maintain and improve
brain health. The Council translates scientific research into action-
able recommendations for the public that will help drive behavior
change in individuals across communities and cultures. 2019 repre-
sents a milestone year for the Council as it prepares to address the
last major lifestyle factor in our systematic review of topics based
on the 2015 AARP Survey on Brain Health. This presentation will
provide highlights from the multi-year effort to systematically
examine lifestyle factors including topics such as physical activity,
sleep, cognitively stimulating activities, and nutrition. This body of
work will serve as the springboard for future Council work.
Methods: Issue specialists from around the world were brought
together to build consensus and issue lifestyle recommendations
based upon the cumulative body of evidence. These experts have
conducted research that has significantly contributed to the body
of evidence linking a range of modifiable risk factors with brain
health in older adults. Results: This presentation will feature
consensus points and recommendations issued by the Council. It
will also showcase statements and practical tips generated by the
Council that are based on the latest research advancements. Data
from surveys fielded by AARP research, developed in consultation
with the GCBH, will also be featured. Conclusions: In sum, this pre-
sentation will highlight the work of the Council at the forefront of
this international effort. Particular emphasis will be paid to the sci-
entific and policy dimensions of brain health, with an emphasis on
individuals aged 50 and older.ORAL SESSIONS
O3-06
NEUROPSYCHOLOGY: NOVEL METHODS OF DETECTING
COGNITIVE CHANGEO3-06-01 NIH TOOLBOX COGNITION TABLETBATTERY IN IDENTIFICATION OF EARLY
COGNITIVE IMPAIRMENTYonatan Kahsay1, Natcha Srimaneerungroj1, Arijit K. Bhaumik1,2,
Tanisha G. Hill-Jarrett1, Annalise rahman-Filipiak1,
Voyko Kavcic3,4, Nicolas May1, Sarah Shair1,2,
Stephen Campbell1,2, Henry L. Paulson1,2, Judith L. Heidebrink1,2,
Benjamin M. Hampstead1,2,5, Bruno Giordani1,2, 1Michigan
Alzheimer’s Disease Center, Ann Arbor, MI, USA; 2University of
Michigan, Ann Arbor, MI, USA; 3Wayne State University, Detroit,
MI, USA; 4International Institute of Applied Gerontology,
Ljubljana, Slovenia; 5VA Ann Arbor Healthcare System, Ann
Arbor, MI, USA. Contact e-mail: giordani@med.umich.eduBackground: The computer-based NIH Toolbox-Cognition battery
includes subtests measuring executive function (Dimensional
Card Sort), episodic memory (Picture Sequence Memory), lan-
guage (Vocabulary, Oral Reading), processing speed (Pattern
Comparison), working memory (List Sorting), and attention
(Attention/Flanker) and is now available on a tablet platform.
The battery was designed by an expert panel to provide valid
and reliable data in epidemiological and longitudinal research,
in order to present a “common currency” for studies. For this
reason, Toolbox has particular appeal for longitudinal studies of
aging and early detection of dementia. The present study was de-
signed to gain information about the ability of Toolbox-Cognition
to differentiate healthy controls from persons with mild cognitive
impairment (MCI). Methods: A sample of consensus-diagnosed
Healthy Controls (HC; N¼61; Age¼69.367.9), Amnestic MCI
single or multiple domain (aMCI; N¼42, Age¼74.167.7), and
non-Amnestic MCI single or multiple domain (naMCI; N¼16;
Age-71.568.8) participants recruited from the Michigan Alz-
heimer’s Disease Core Center (MADCC) were administered the
NIH Toolbox-Cognition battery. The sample included 67 African
Americans and 52 non-Hispanic white participants. Data from the
core subtests u sing the iPad tablet Toolbox app were chosen for
analyses in this paper to compare across groups using a multivar-
iate analysis of variance model. Results: Groups did not differ in
age or education. The overall MANOVA model was significant
(p<.0001). Across individual subtests that demonstrated signifi-
cant differences, the Flanker test demonstrated better performance
by controls compared to aMCI (p<.01). For List Sorting, Controls
performed better than both aMCI (p<.002) and naMCI (p<.01).
For Picture Sequence Memory, Controls performed better than
aMCI (p<.0001), and naMCI performed better than aMCI
(p<.002). No differences were noted for race. No differences
were seen for Card Sort, Oral Reading, Pattern Comparison, and
Vocabulary. Discriminant analysis classified Controls from MCI
at an overall rate of 77% and aMCI from naMCI at 76%. Conclu-
sions: aMCI differed from controls on measures of attention,
working memory, and memory, and naMCI differed from controls
only on working memory. aMCI and naMCI differed only on
memory. The tablet version of Toolbox-Cognition appears to be
a reasonable measure to reflect differences across early age- and
illness-associated cognitive changes.
